Cargando…
Bioactive Lipids as Chronic Myeloid Leukemia’s Potential Biomarkers for Disease Progression and Response to Tyrosine Kinase Inhibitors
Chronic myelogenous leukemia (CML) is a myeloproliferative neoplasm that expresses the Philadelphia chromosome and constitutively activated Bcr-Abl tyrosine kinase in hematopoietic progenitor cells. Bcr-Abl tyrosine-kinase inhibitors (TKI) do not definitively cure all CML patients. The efficacy of T...
Autores principales: | de Almeida, Felipe Campos, Berzoti-Coelho, Maria G., Toro, Diana Mota, Cacemiro, Maira da Costa, Bassan, Vitor Leonardo, Barretto, Gabriel Dessotti, Garibaldi, Pedro Manoel Marques, Palma, Leonardo Carvalho, de Figueiredo-Pontes, Lorena Lobo, Sorgi, Carlos Arterio, Faciolli, Lucia Helena, Gardinassi, Luiz Gustavo, de Castro, Fabíola Attié |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043757/ https://www.ncbi.nlm.nih.gov/pubmed/35493444 http://dx.doi.org/10.3389/fimmu.2022.840173 |
Ejemplares similares
-
Philadelphia-negative myeloproliferative neoplasms display alterations in monocyte subpopulations frequency and immunophenotype
por: Bassan, Vitor Leonardo, et al.
Publicado: (2022) -
Differential cytokine network profile in polycythemia vera and secondary polycythemia
por: Cacemiro, Maira da Costa, et al.
Publicado: (2020) -
Bone Marrow Soluble Mediator Signatures of Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
por: Cominal, Juçara Gastaldi, et al.
Publicado: (2021) -
MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia
por: Rabello, Doralina do Amaral, et al.
Publicado: (2018) -
Philadelphia-negative myeloproliferative neoplasms as disorders marked by cytokine modulation
por: Cacemiro, Maira da Costa, et al.
Publicado: (2018)